公开(公告)号：US11858990B2

公开(公告)日：2024-01-02

申请号：US16804018

申请日：2020-02-28

Applicant: INNATE PHARMA

Inventor： Laurent Gauthier ,  Simon Kollnberger ,  Benjamin Rossi ,  Hélène Sicard ,  Carine Paturel ,  Stéphanie Cornen ,  Stéphanie Zerbib

IPC: A61P35/00 ,  C07K16/28 ,  G01N33/569 ,  A61K39/00

CPC classification number: C07K16/2803 ,  G01N33/56966 ,  G01N33/56972 ,  A61K2039/505 ,  C07K2317/33 ,  C07K2317/34 ,  C07K2317/565 ,  C07K2317/732 ,  C07K2317/734 ,  C07K2317/76 ,  C07K2317/77 ,  G01N2333/70503 ,  G01N2800/24 ,  G01N2800/52 ,  G01N2800/7095

Abstract: The present invention relates to methods for the treatment of cancer and inflammatory disease using antibodies (e.g. monoclonal antibodies), antibody fragments, and derivatives thereof that specifically bind KIR3DL2. The invention also relates to antibodies, cells producing such antibodies; methods of making such antibodies; fragments, variants, and derivatives of the antibodies; pharmaceutical compositions comprising the same.

公开(公告)号：US10577419B2

公开(公告)日：2020-03-03

申请号：US14662349

申请日：2015-03-19

Applicant: INNATE PHARMA

Inventor： Laurent Gauthier ,  Simon Kollnberger ,  Benjamin Rossi ,  Hélène Sicard ,  Carine Paturel ,  Stéphanie Cornen ,  Stéphanie Zerbib

IPC: C07K16/28 ,  G01N33/569 ,  A61K39/00

Abstract: The present invention relates to methods for the treatment of cancer and inflammatory disease using antibodies (e.g. monoclonal antibodies), antibody fragments, and derivatives thereof that specifically bind KIR3DL2. The invention also relates to antibodies, cells producing such antibodies; methods of making such antibodies; fragments, variants, and derivatives of the antibodies; pharmaceutical compositions comprising the same.